BlackRock’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

BlackRock’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-7,414	Closed	-$201K	–	3803
2015 Q4	$201K	Sell	7,414 -2,334	-24%	-$60.1K	﹤0.01%	1653
2015 Q3	$213K	Sell	9,748 -1,586	-14%	-$40.5K	﹤0.01%	1625
2015 Q2	$323K	Sell	11,334 -20,499	-64%	-$597K	﹤0.01%	1615
2015 Q1	$871K	Sell	31,833 -7,027	-18%	-$193K	﹤0.01%	1387
2014 Q4	$1.03M	Sell	38,860 -3,002	-7%	-$87.9K	﹤0.01%	1201
2014 Q3	$1.26M	Sell	41,862 -23,350	-36%	-$723K	﹤0.01%	1160
2014 Q2	$2.05M	Buy	65,212 +27,217	+72%	+$864K	﹤0.01%	1034
2014 Q1	$1.23M	Sell	37,995 -2,963	-7%	-$104K	﹤0.01%	1164
2013 Q4	$1.49M	Buy	40,958 +15,314	+60%	+$595K	﹤0.01%	1085
2013 Q3	$997K	Sell	25,644 -694	-3%	-$28K	﹤0.01%	1087
2013 Q2	$986K	Buy	+26,338	New	+$1.04M	﹤0.01%	1057

Other funds holding MR

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BlackRock's MR Position: Q1 2016 in Review

BlackRock sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 7,414 shares — an estimated $201K sold.

BlackRock first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $2.05M in Q2 2014. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

BlackRock reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
BlackRock sold 7,414 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $201K.
BlackRock first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
BlackRock's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $2.05M in Q2 2014.
2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on BlackRock's 13F filing for Q1 2016, filed 10 May 2016.